178 related articles for article (PubMed ID: 34910890)
1. RAGE-mediated T cell metabolic reprogramming shapes T cell inflammatory response after stroke.
Zhang Y; Li F; Chen C; Li Y; Xie W; Huang D; Zhai X; Yu W; Wan J; Li P
J Cereb Blood Flow Metab; 2022 Jun; 42(6):952-965. PubMed ID: 34910890
[TBL] [Abstract][Full Text] [Related]
2. ACC1 (Acetyl Coenzyme A Carboxylase 1) Is a Potential Immune Modulatory Target of Cerebral Ischemic Stroke.
Wang X; Zhou Y; Tang D; Zhu Z; Li Y; Huang T; Müller R; Yu W; Li P
Stroke; 2019 Jul; 50(7):1869-1878. PubMed ID: 31177975
[TBL] [Abstract][Full Text] [Related]
3. MiR-24-3p enhances the Treg/Th17 balance to improve cerebral ischemic injury by suppressing acetyl-CoA carboxylase 1 expression.
Wang Y; Yang Y; Xie L; An X; Zhang L
J Neuroimmunol; 2024 May; 390():578344. PubMed ID: 38640826
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end products promote differentiation of CD4(+) T helper cells toward pro-inflammatory response.
Han XQ; Gong ZJ; Xu SQ; Li X; Wang LK; Wu SM; Wu JH; Yang HF
J Huazhong Univ Sci Technolog Med Sci; 2014 Feb; 34(1):10-17. PubMed ID: 24496672
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of soluble RAGE in mesenchymal stem cells enhances their immunoregulatory potential for cellular therapy in autoimmune arthritis.
Park MJ; Lee SH; Moon SJ; Lee JA; Lee EJ; Kim EK; Park JS; Lee J; Min JK; Kim SJ; Park SH; Cho ML
Sci Rep; 2016 Nov; 6():35933. PubMed ID: 27804999
[TBL] [Abstract][Full Text] [Related]
6. The myocardial infarct-exacerbating effect of cell-free DNA is mediated by the high-mobility group box 1-receptor for advanced glycation end products-Toll-like receptor 9 pathway.
Tian Y; Charles EJ; Yan Z; Wu D; French BA; Kron IL; Yang Z
J Thorac Cardiovasc Surg; 2019 Jun; 157(6):2256-2269.e3. PubMed ID: 30401529
[TBL] [Abstract][Full Text] [Related]
7. The HMGB1 receptor RAGE mediates ischemic brain damage.
Muhammad S; Barakat W; Stoyanov S; Murikinati S; Yang H; Tracey KJ; Bendszus M; Rossetti G; Nawroth PP; Bierhaus A; Schwaninger M
J Neurosci; 2008 Nov; 28(46):12023-12031. PubMed ID: 19005067
[TBL] [Abstract][Full Text] [Related]
8. sRAGE alleviates neutrophilic asthma by blocking HMGB1/RAGE signalling in airway dendritic cells.
Zhang F; Su X; Huang G; Xin XF; Cao EH; Shi Y; Song Y
Sci Rep; 2017 Oct; 7(1):14268. PubMed ID: 29079726
[TBL] [Abstract][Full Text] [Related]
9. Soluble receptor for advanced glycation end products protects from ischemia- and reperfusion-induced acute kidney injury.
Miyagawa T; Iwata Y; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Kamikawa Y; Miyake T; Kitajima S; Toyama T; Hara A; Sakai N; Shimizu M; Furuichi K; Munesue S; Yamamoto Y; Kaneko S; Wada T
Biol Open; 2022 Jan; 11(1):. PubMed ID: 34812852
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection by the PARP inhibitor PJ34 modulates cerebral and circulating RAGE levels in rats exposed to focal brain ischemia.
Greco R; Tassorelli C; Mangione AS; Levandis G; Certo M; Nappi G; Bagetta G; Blandini F; Amantea D
Eur J Pharmacol; 2014 Dec; 744():91-7. PubMed ID: 25446913
[TBL] [Abstract][Full Text] [Related]
11. Soluble receptor for advanced glycation end-products promotes angiogenesis through activation of STAT3 in myocardial ischemia/reperfusion injury.
Cao X; Li B; Han X; Zhang X; Dang M; Wang H; Du F; Zeng X; Guo C
Apoptosis; 2020 Jun; 25(5-6):341-353. PubMed ID: 32333220
[TBL] [Abstract][Full Text] [Related]
12. JNK and ATF4 as two important platforms for tumor necrosis factor-α-stimulated shedding of receptor for advanced glycation end products.
Miyoshi A; Koyama S; Sasagawa-Monden M; Kadoya M; Konishi K; Shoji T; Inaba M; Yamamoto Y; Koyama H
FASEB J; 2019 Mar; 33(3):3575-3589. PubMed ID: 30452882
[TBL] [Abstract][Full Text] [Related]
13. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
[TBL] [Abstract][Full Text] [Related]
14. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
Melin EO; Dereke J; Hillman M
Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
[TBL] [Abstract][Full Text] [Related]
15. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
Son M; Oh S; Park H; Ahn H; Choi J; Kim H; Lee HS; Lee S; Park HJ; Kim SU; Lee B; Byun K
Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
[TBL] [Abstract][Full Text] [Related]
16.
López-Díez R; Shen X; Daffu G; Khursheed M; Hu J; Song F; Rosario R; Xu Y; Li Q; Xi X; Zou YS; Li H; Schmidt AM; Yan SF
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1536-1547. PubMed ID: 28642238
[TBL] [Abstract][Full Text] [Related]
17. Circulating soluble RAGE and cell surface RAGE on peripheral blood mononuclear cells in healthy children.
García-Salido A; Melen G; Gómez-Piña V; Oñoro-Otero G; Serrano-González A; Casado-Flores J; Ramírez M
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):649-654. PubMed ID: 29723156
[TBL] [Abstract][Full Text] [Related]
18. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells.
Berod L; Friedrich C; Nandan A; Freitag J; Hagemann S; Harmrolfs K; Sandouk A; Hesse C; Castro CN; Bähre H; Tschirner SK; Gorinski N; Gohmert M; Mayer CT; Huehn J; Ponimaskin E; Abraham WR; Müller R; Lochner M; Sparwasser T
Nat Med; 2014 Nov; 20(11):1327-33. PubMed ID: 25282359
[TBL] [Abstract][Full Text] [Related]
19. Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells.
Leung SS; Borg DJ; McCarthy DA; Boursalian TE; Cracraft J; Zhuang A; Fotheringham AK; Flemming N; Watkins T; Miles JJ; Groop PH; Scheijen JL; Schalkwijk CG; Steptoe RJ; Radford KJ; Knip M; Forbes JM
Diabetes; 2022 Sep; 71(9):1994-2008. PubMed ID: 35713929
[TBL] [Abstract][Full Text] [Related]
20. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.
Bucciarelli LG; Kaneko M; Ananthakrishnan R; Harja E; Lee LK; Hwang YC; Lerner S; Bakr S; Li Q; Lu Y; Song F; Qu W; Gomez T; Zou YS; Yan SF; Schmidt AM; Ramasamy R
Circulation; 2006 Mar; 113(9):1226-34. PubMed ID: 16505177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
